title: Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
authors.forename: John David
authors.initials: JD
authors.lastname: Spence
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D001384:Azetidines / Q000008:administration & dosage*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D019821:Simvastatin / Q000008:administration & dosage*
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D019821:Simvastatin